If it is green-lighted by the Food and Drug Administration, the vaccine is expected to offer protection for only a few months, and it would likely be available only to health workers at first. But Schleifer said the vaccine could be used down the line as"something therapeutic" if administered in higher doses.
Less than 30 miles from Regeneron's labs, a growing cluster of coronavirus cases prompted New York Gov. Andrew Cuomo to implement aone-mile"There is currently no treatment for the virus, and those who are infected are being treated only for symptoms, including medication to lower fevers and cough associated with COVID-19, the illness caused by the virus.
But Regeneron said it's hopeful that it will come up with a treatment, just as it did for several other viruses, including Ebola.The company used a similar technique to develop an antibody treatment that dramatically boosted Ebola survival rates in Africa.
"I think this is probably the biggest moment for our industry in terms of everybody in the industry wanting to do the right thing," Schleifer said."They want to make a difference. And they want to show the world."Jay Blackman is an NBC News producer covering such areas a transportation, space, medical and consumer issues.
Wishing you much success.
Yeah but the real question is how much will it cost? You know it’s Profits before People!